Literature DB >> 23277057

Biomimetic materials for controlling bone cell responses.

Olivier Drevelle1, Nathalie Faucheux.   

Abstract

Bone defects that cannot "heal spontaneously during life" will become an ever greater health problem as populations age. Harvesting autografts has several drawbacks, such as pain and morbidity at both donor and acceptor sites, the limited quantity of material available, and frequently its inappropriate shape. Researchers have therefore developed alternative strategies that involve biomaterials to fill bone defects. These biomaterials must be biocompatible and interact with the surrounding bone tissue to allow their colonization by bone cells and blood vessels. The latest generation biomaterials are not inert; they control cell responses like adhesion, proliferation and differentiation. These biomaterials are called biomimetic materials. This review focuses on the development of third generation materials. We first briefly describe the bone tissue with its cells and matrix, and then how bone cells interact with the extracellular matrix. The next section covers the materials currently used to repair bone defects. Finally, we describe the strategies employed to modify the surface of materials, such as coating with hydroxyapatite and grafting biomolecules.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277057     DOI: 10.2741/s378

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  2 in total

1.  Environment and bone regeneration: how biomaterials, host mediators and even bacterial products can boost bone cells towards better clinical outcomes.

Authors:  Gustavo Pompermaier Garlet
Journal:  J Appl Oral Sci       Date:  2015 Mar-Apr       Impact factor: 2.698

2.  Preclinical safety study of a combined therapeutic bone wound dressing for osteoarticular regeneration.

Authors:  Laetitia Keller; Luc Pijnenburg; Ysia Idoux-Gillet; Fabien Bornert; Laila Benameur; Maryam Tabrizian; Pierrick Auvray; Philippe Rosset; Rosa María Gonzalo-Daganzo; Enrique Gómez Barrena; Luca Gentile; Nadia Benkirane-Jessel
Journal:  Nat Commun       Date:  2019-05-14       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.